FELICIA MENDONCA: Open Payments
NPI 1578172243 · N DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 21 payments from 9 companies in 2025. Trend: 2023 $472 · 2024 $484 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $87 |
| E.R. Squibb & Sons, L.L.C. | 3 | $80 |
| GENZYME CORPORATION | 3 | $70 |
| ABBVIE INC. | 3 | $69 |
| Regeneron Healthcare Solutions, Inc. | 2 | $67 |
| LEO Pharma Inc. | 2 | $57 |
| Organon LLC | 1 | $31 |
| Janssen Biotech, Inc. | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
Products named: DUPIXENT, Sotyktu, COSENTYX, RINVOQ, Rhapsido, ANZUPGO, SKYRIZI, ADBRY.
Industry payments across MA — which companies pay providers there.
